ESTA ESTABLISHMENT LABS HOLDINGS INC.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1688757 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY38.3%
TTM net income YoY53.7%
TTM EPS YoY55.3%
Revenue 3-yr CAGR14.2%
Net income 3-yr CAGR—
Margins
Gross margin70.2%
Operating margin-6.6%
Net margin-14.6%
FCF margin-8.2%
EBITDA margin—
Returns
ROE-240.7%
ROA-11.0%
ROIC (approx.)-6.7%
Asset turnover0.76x
Leverage & solvency
Liabilities / assets95.7%
Debt / equity17.17x
Current ratio3.57x
Interest coverage-0.62x
Cash quality & payout
Operating cash flow / net income0.35x
Accruals ratio-7.2%
Payout ratio—
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $71.99M | $67.54M | $59.88M | $64.62M | $53.78M | $51.30M | $41.38M | $44.51M |
| Cost of revenue | $22.28M | $19.83M | $17.54M | $19.09M | $16.09M | $16.03M | $13.57M | $14.02M |
| Gross profit | $49.71M | $47.71M | $42.34M | $45.53M | $37.70M | $35.27M | $27.81M | $30.49M |
| R&D expense | $4.31M | $5.10M | $5.24M | $5.43M | $4.55M | $5.20M | $5.05M | $5.14M |
| SG&A expense | $48.02M | $46.91M | $43.60M | $44.03M | $37.17M | $44.18M | $39.70M | $44.02M |
| Operating income | -$2.62M | -$4.29M | -$6.51M | -$3.93M | -$4.03M | -$14.11M | -$16.95M | -$18.67M |
| Interest expense | $6.81M | $7.03M | $7.09M | $7.24M | $6.20M | $5.96M | $5.85M | $5.95M |
| Pretax income | -$10.10M | -$11.74M | -$13.09M | -$11.91M | -$10.72M | -$15.59M | -$19.80M | -$35.94M |
| Income tax | $612,000 | $6,000 | $288,000 | -$9.30M | $424,000 | $1.00M | $914,000 | -$1.41M |
| Net income | -$10.71M | -$11.75M | -$13.38M | -$2.62M | -$11.15M | -$16.59M | -$20.71M | -$34.53M |
| EBITDA | — | — | -$4.91M | -$2.43M | -$2.52M | -$12.51M | -$15.35M | -$17.17M |
| EPS (basic) | -0.35 | -0.39 | -0.45 | — | -0.38 | -0.57 | -0.70 | — |
| EPS (diluted) | -0.35 | -0.39 | -0.45 | — | -0.38 | -0.57 | -0.70 | — |
| Weighted avg. shares (diluted) | 30.43M | 30.12M | 29.95M | — | 29.62M | 28.91M | 29.48M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $75.81M | $71.16M | $68.10M | $75.57M | $70.62M | $54.64M | $69.18M | $90.35M |
| Receivables | $77.92M | $75.65M | $77.08M | $77.50M | $71.44M | $70.09M | $63.24M | $65.00M |
| Inventory | $85.01M | $84.98M | $86.66M | $85.61M | $88.16M | $94.68M | $90.42M | $78.77M |
| Current assets | $255.72M | $247.73M | $245.83M | $249.94M | $239.60M | $229.17M | $231.70M | $243.04M |
| PP&E, net | $73.31M | $74.00M | $74.65M | $75.61M | $76.24M | $76.36M | $76.39M | $78.03M |
| Goodwill | $1.21M | $1.21M | $1.21M | $1.21M | $1.21M | $1.21M | $1.21M | $1.21M |
| Intangibles | $9.29M | $9.43M | $9.30M | $9.94M | $10.40M | $11.19M | $11.57M | $11.68M |
| Total assets | $358.88M | $351.93M | $351.04M | $357.17M | $338.89M | $329.67M | $333.36M | $346.83M |
| Current liabilities | $71.61M | $64.56M | $83.15M | $82.14M | $71.98M | $80.74M | $69.04M | $68.28M |
| Short-term debt | — | — | — | — | $10.00M | $5.00M | — | $0 |
| Long-term debt | $267.82M | $261.70M | $248.59M | $247.52M | $246.46M | $221.13M | $220.34M | $219.58M |
| Total debt | $267.82M | $261.70M | $248.59M | $247.52M | $256.46M | $226.13M | $220.34M | $219.58M |
| Total liabilities | $343.28M | $330.32M | $336.25M | $333.62M | $322.53M | $306.90M | $294.81M | $293.74M |
| Shareholders' equity | $15.59M | $21.61M | $14.78M | $23.55M | $16.36M | $22.76M | $38.55M | $53.09M |
| Net debt | $192.01M | $190.54M | $180.49M | $171.95M | $185.83M | $171.49M | $151.16M | $129.23M |
| Shares outstanding | 29.82M | 29.79M | 29.39M | 29.30M | 29.06M | 28.97M | 28.91M | 28.79M |
| Cash flow statement | ||||||||
| Operating cash flow | $7.70M | -$16.60M | -$4.31M | -$162,000 | -$11.25M | -$18.75M | -$20.73M | -$20.75M |
| Capital expenditure | $885,000 | $3.66M | $1.85M | $1.82M | $1.85M | $1.62M | $753,000 | $531,000 |
| Free cash flow | $6.81M | -$20.26M | -$6.16M | -$1.99M | -$13.10M | -$20.38M | -$21.48M | -$21.28M |
| Investing cash flow | -$2.63M | -$3.65M | -$1.96M | -$1.66M | -$1.96M | -$2.07M | -$1.34M | -$1.82M |
| Financing cash flow | -$99,000 | $23.46M | -$864,000 | $6.05M | $29.45M | $5.13M | -$203,000 | $74.49M |
| Depreciation & amortization | — | — | $1.60M | $1.50M | $1.50M | $1.60M | $1.60M | $1.50M |
| Stock-based compensation | $2.95M | $3.23M | $3.00M | $2.90M | $2.89M | $3.19M | $2.43M | $3.55M |
Free plan shows the latest 8 periods; Pro shows all 38 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.